ARCHIVES

Cervical Screening Should Emphasize Older Women, ASP Members Told

This article is from The Cancer Letter archive.

Vol. 12 No. 11 | March 14, 1986

Download PDF Visit The Full Archive

Related Articles

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991